Site Inspections

The full MOH inspections records is available at the bottom of Quality & Compliance page

 

 

  • On September 1st TAPI has a successful inspection at TAPI-Czech by Czech MOH.

 

  • On July 18-19 TAPI had a successful inspection in TPC site by China regulatory agencies. 

 

  • On May 9-12 TAPI had a successful inspection in Santhia site by AIFA.

 

  • On April 12 TAPI had a successful inspection in Pliva by HALMED (Croatian MOH).

 

  • On April 12 TAPI had a successful inspection in Rho by AIFA (Italian MOH).

 

  • On April 10th TAPI had a successful inspection in Teva Tech by FDA.

 

  • On March 28th TAPI had a successful inspection in TIM by WHO

 

  • On March 8th TAPI had a successful inspection in Caronno by by AIFA (Italian MOH).

 

  • On September 2015 the Israel-based Plantex Site was successfully audited by the Kazakhstan MOH.

  • On August 2015 Sicor de Mexico Site was successfully audited by the South African MOH. 

  • In June 2015 the China based Teva Pharmaceutical & Chemical (Hangzhou) Site was successfully audited by the Chinese MOH (CFDA). The inspection took place between June 29 and July 1, 2015. 

  • On June 2015 Successful Inspection for TAPI in China manufacturing site - Hangzhou.
    In this site we have manufacturing units for APIs and advanced intermediates, as well as one mini plant. The site has FDA and CFDA approvals.

 

  •  TAPI's Pliva Savski Marof (SM) site in Prigorje Brdovecko, Croatia, successfully passed an audit by the Brazilian Health Surveillance Agency (Anvisa). The on-site audit was conducted between December 1-4, 2014. Anvisa also successfully inspected the Bulciago site in Bulciago, Italy, between December 2-5.   

  • On November 2014 Humacao Site Successfully Passes Audit Conducted by FDA

  • On January 2014 FDA Completes Successful Audit of Rho Plant in Italy

  • On October 2013 AIFA Completes Successful Inspection of Santhia Plant in Italy

  • Petach Tikva, Israel – September 3, 2013 – TAPI announced today that its TPC plant in Hangzhou, China, successfully passed an inspection by the FDA.

  • On August 2013 Successful Inspection for TAPI in China manufacturing site - Hangzhou.
    In this site we have manufacturing units for APIs and advanced intermediates, as well as one mini plant. The site has FDA and approvals.

 


  • Petach Tikva, Israel – June 26, 2013 – TAPI announced today that that its Sicor de Mexico plant in Lerma Estado de Mexico, Mexico, successfully passed an audit by the  Mexican Ministry of Health.
    The Mexican Ministry of Health mission is to “contribute to universal access to comprehensive and high quality integral services that meet the needs and meet the expectations of the population”.


  • Petach Tikva, Israel – June 18, 2013 – TAPI announced today that its Debrecen site in Debrecen, Hungary, successfully passed an inspection by the FDA. The on-site audit was conducted during the period of June 10-14, 2013. 

  • On May 2013 Sajobabony successfully audited by Hungarian National Institute of Pharmacy (NIP)


  • On May 2013 Teva Tech successfully inspected by KFDA

  • On March 2013 FDA completes audit of Settimo plant

  • Petach Tikva, Israel – February 28, 2013 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Debrecen site in Debrecen, Hungary, successfully passed an inspection by the Hungarian National Institute of Pharmacy (NIP).

    The NIP, the Hungarian regulatory authority, is responsible among others for issuing GMP licenses and for conducting inspections. 

    The on-site audit was conducted during the period of February 12-13, 2013.

  • Petach Tikva, Israel – December 25, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that the Italian Medicines Agency (AIFA) recently completed a successful audit of the Settimo plant in Settimo Milanese, Italy.
    The on-site inspection was conducted during the period of December 17-20, 2012.

    The AIFA, Italy’s national authority responsible for drugs regulation, operates under the direction of the Italian Ministry of Health.


  • Petach Tikva, Israel – December 14, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Malanpur site in Malanpur, India, successfully passed an inspection by the Korean FDA (KFDA).

    The KFDA is performing Good Manufacturing Practices (GMP) inspections and evaluations for domestic and imported drugs, among others. The on-site audit was conducted during the period of December 10-11, 2012.

  • Petach Tikva, Israel – December 3, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that the U.S. Food and Drug Administration (FDA) recently completed a successful inspection of the Caronno plant in Caronno Pertusella, Italy. 
    The on-site audit was conducted during the period of November 26-29, 2012.
    The Food and Drug Administration is an agency within the U.S. Department of Health and Human Services.

  • Petach Tikva, Israel – October 25, 2012TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Santhia site in Santhia, Italy, successfully passed an audit by the Chinese State Food and Drug Administration (SFDA). One of the SFDA’s responsibilities is to take charge of administrative and technical supervision of drugs and medical devices.

    It was the very first inspection that the SFDA has conducted of a TAPI site. The on-site audit took place during the period of October 14-20, 2012.


  • FDA Completes Successful Audit of Villanterio plant 
    Petach Tikva, Israel – October 3, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Villanterio site in Villanterio, Italy, passed an audit by the U.S. Food and Drug Administration (FDA).

    The on-site inspection was conducted by the FDA during the period of September 24-28, 2012.


  • Petach Tikva, Israel – August 23, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Plantex and Abic sites both successfully passed an audit by the Therapeutic Goods Administration (TGA), Australia’s regulatory body for therapeutic goods. The two sites are based in Israel.
    The on-site inspection at Plantex was conducted by the TGA during the period of August 2-6, the inspection at Abic during August 7-8, 2012.


  • Petach Tikva, Israel – August 6, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Teva Tech site in Beer Sheva, Israel, successfully passed an inspection by the Therapeutic Goods Administration (TGA), Australia’s regulatory body for therapeutic goods.
    The on-site inspection was conducted by the TGA on July 25, 26 & 29, 2012.

  • Petach Tikva, Israel – July 30, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that the Italian Medicines Agency (AIFA), Italy’s national authority responsible for drugs regulation, recently completed a successful inspection of the Rho plant in Milano, Italy. The AIFA operates under the direction of the Italian Ministry of Health.
    The on-site audit was conducted during the period of July 23-26, 2012.


  • Petach Tikva, Israel – July 26, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Plantex site in Netanya, Israel, successfully passed an inspection by the Korean FDA (KFDA). The KFDA is performing Good Manufacturing Practices (GMP) inspections and evaluations for domestic and imported drugs, among others.
    The on-site inspection was conducted during the period of July 9-11, 2012.

  • On July 2012 Korean FDA Completes Successful Inspection of Santhia Site

  • Petach Tikva, Israel – June 11, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that the U.S. Food and Drug Administration (FDA) completed the inspection of its Gajraula plant in Gajraula, Uttar Pradesh, India.

    The on-site audit took place between of June 4-6, 2012. 


  • On June 2012 Korean FDA Completes Successful Audit of Guayama Site

  • Petach Tikva, Israel – May 31, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its Guayama site in Guayama, Puerto Rico, successfully passed an audit by the Therapeutic Goods Administration (TGA), Australia’s regulatory body for therapeutic goods.
     The on-site inspection was conducted by the TGA during the period of May 10-18, 2012.


  • Petach Tikva, Israel – May 13, 2012 – TAPI, the leading international supplier of active pharmaceutical ingredients (APIs), announced today that its TAPI India Malanpur (TIM) plant in Malanpur, India, successfully passed an audit by the Therapeutic Goods Administration (TGA), Australia’s regulatory body for therapeutic goods.
    The on-site inspection was conducted by the TGA in the beginning of May 2012.


  • On May 2012 Sicor Plant in Mexico Successfully Passes Inspection Audit by TGA

  • The Israel-based Abic API Site underwent an inspection by the Israeli Ministry of Health. The successful audit was conducted between March 18 and 20, 2012.


  • The Israel-based Plantex Site was successfully inspected by the German Ministry of Health and the Israeli Ministry of Health in March 2012.


  • The Croatian Ministry of Health successfully audited the two Croatia-based Pliva Sites (Savski Marof and PbF) on February 17, 2012.


  • Successful 2012 audit of Hungarian plant